FIELD: chemistry.
SUBSTANCE: invention relates to pyridine compounds of pladienolide of formulas 1–4, to pharmaceutical compositions containing similar compounds, and to methods of using said compounds as therapeutic agents.
4.
EFFECT: technical result is obtaining novel compounds and pharmaceutical compositions based thereon, which can be used in medicine for treating oncological diseases, in particular, in which agents are targeting a spliceosome and its mutations.
53 cl, 7 tbl, 10 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDINE COMPOUNDS OF PLADIENOLIDE AND METHODS OF THEIR USE | 2015 |
|
RU2807278C2 |
| COMBINATION INCLUDING AT LEAST ONE SPLICEOSOME MODULATOR AND AT LEAST ONE INHIBITOR SELECTED FROM BCL2 INHIBITORS, BCL2/BCLXL INHIBITORS, AND BCLXL INHIBITORS, AS WELL AS APPLICATION METHODS | 2018 |
|
RU2783239C2 |
| SOLID FORMS OF PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS FOR USE THEREOF | 2016 |
|
RU2743349C2 |
| SPECIFIC PLADIENOLIDE COMPOUNDS AND METHODS OF THEIR USE | 2019 |
|
RU2813597C2 |
| PLADIENOLIDE DERIVATIVES AS DRUGS WITH TARGETED INFLUENCE ON SPLICEOSOME FOR TREATMENT OF CANCER | 2019 |
|
RU2815064C2 |
| ANTIBODY AND DRUG CONJUGATES AS A SPLICING MODULATOR AND METHODS OF THEIR USE | 2019 |
|
RU2799438C2 |
| HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FOR USE AGAINST CANCER AND VIRAL INFECTIONS | 2015 |
|
RU2766087C2 |
| DIARYLTHIOHYDATOIC COMPOUNDS | 2007 |
|
RU2449993C2 |
| INHIBITORS OF NOTCH SIGNAL TRANSMISSION WAYS AND THEIR APPLICATION FOR CANCER TREATMENT | 2012 |
|
RU2631611C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2662436C2 |
